Campo G - Search Results

1

Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: systematic review and meta-analysis of randomized clinical trials.

Pavasini R, Serenelli M, Gallo F, Bugani G, Geraci S, Vicinelli P, Campo G. Pavasini R, et al. Among authors: campo g. J Thorac Dis. 2017 Aug;9(Suppl 9):S887-S897. doi: 10.21037/jtd.2017.06.59. J Thorac Dis. 2017. PMID: 28894594 Free PMC article.

2

Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients?

Campo G, Pavasini R, Pollina A, Fileti L, Marchesini J, Tebaldi M, Ferrari R. Campo G, et al. Blood Coagul Fibrinolysis. 2012 Dec;23(8):680-7. doi: 10.1097/MBC.0b013e328355111f. Blood Coagul Fibrinolysis. 2012. PMID: 22688556 Review.

3

The in vitro effects of verbascoside on human platelet aggregation.

Campo G, Marchesini J, Bristot L, Monti M, Gambetti S, Pavasini R, Pollina A, Ferrari R. Campo G, et al. J Thromb Thrombolysis. 2012 Oct;34(3):318-25. doi: 10.1007/s11239-012-0757-z. J Thromb Thrombolysis. 2012. PMID: 22723176 Clinical Trial.

4

Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes.

Campo G, Pavasini R, Pollina A, Tebaldi M, Ferrari R. Campo G, et al. Thromb Res. 2013 Aug;132(2):151-7. doi: 10.1016/j.thromres.2013.06.007. Epub 2013 Jul 2. Thromb Res. 2013. PMID: 23827698 Review.

5

On-treatment platelet reactivity in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.

Campo G, Pavasini R, Pollina A, Tebaldi M, Ferrari R. Campo G, et al. Thorax. 2014 Jan;69(1):80-1. doi: 10.1136/thoraxjnl-2013-203608. Epub 2013 Jul 22. Thorax. 2014. PMID: 23878160

6

Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury.

Morciano G, Giorgi C, Bonora M, Punzetti S, Pavasini R, Wieckowski MR, Campo G, Pinton P. Morciano G, et al. Among authors: campo g. J Mol Cell Cardiol. 2015 Jan;78:142-53. doi: 10.1016/j.yjmcc.2014.08.015. Epub 2014 Aug 27. J Mol Cell Cardiol. 2015. PMID: 25172387 Review.

7

Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management.

Campo G, Pavasini R, Malagù M, Mascetti S, Biscaglia S, Ceconi C, Papi A, Contoli M. Campo G, et al. Cardiovasc Drugs Ther. 2015 Apr;29(2):147-57. doi: 10.1007/s10557-014-6569-y. Cardiovasc Drugs Ther. 2015. PMID: 25645653 Review.

8

Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD.

Campo G, Pavasini R, Malagù M, Punzetti S, Napoli N, Guerzoni F, Papi A, Ceconi C, Contoli M. Campo G, et al. COPD. 2015;12(5):560-7. doi: 10.3109/15412555.2014.995293. Epub 2015 Mar 16. COPD. 2015. PMID: 25775224 Free article.

9

Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents.

Biscaglia S, Ferri A, Pavasini R, Campo G, Ferrari R. Biscaglia S, et al. Among authors: campo g. J Atheroscler Thromb. 2015;22(5):535-41. doi: 10.5551/jat.29371. Epub 2015 Apr 3. J Atheroscler Thromb. 2015. PMID: 25843116 Free article. Review.

10

Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study.

Campo G, Pavasini R, Biscaglia S, Ferri A, Andrenacci E, Tebaldi M, Ferrari R. Campo G, et al. Pharmacol Res. 2015 Jul;97:1-6. doi: 10.1016/j.phrs.2015.03.020. Epub 2015 Apr 3. Pharmacol Res. 2015. PMID: 25846253 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

757 results

Search Page

Filters